Neoadjuvant or adjuvant therapy for resectable or borderline resectable pancreatic cancer: Which is preferred? Journal Article


Authors: O'Reilly, E. M.; Ferrone, C.
Article Title: Neoadjuvant or adjuvant therapy for resectable or borderline resectable pancreatic cancer: Which is preferred?
Journal Title: Journal of Clinical Oncology
Volume: 38
Issue: 16
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2020-06-01
Start Page: 1757
End Page: 1759
Language: English
DOI: 10.1200/jco.19.03318
PUBMED: 32119598
PROVIDER: scopus
PMCID: PMC7255981
DOI/URL:
Notes: Editorial -- Export Date: 1 July 2020 -- Source: Scopus
Altmetric
Citation Impact
MSK Authors
  1. Eileen O'Reilly
    443 O'Reilly